RESPIRA THERAPEUTICS, INC.
Engineered inhaled corticosteroid particles (nano-sized drug with low-density leucine carrier particles) for efficient small airway delivery in pediatric asthma
- Sector
- Medtech
- Headquarters
- ALBUQUERQUE, NM
- Latest Form D
- $9.1M, Apr 2017
- Total capital
- $9.3M
- Federal grants
- $225K
- 1 award · 2019
- Rank in peer group#24 of 36
- Private capital raised
- $9.1M
- 1 Form D · last Apr 2017
- 114 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 12
- 23 pending · first 2019
- Rank in peer group#2 of 36
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of a novel dry powder delivery system for delivery of inhaled corticosteroids to the small airways of pediatric asthma patients$225K
- Private capital raisedForm D · SEC · 1st filing$9.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grantsBelow median
- Granted patents#2 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Robert M. CurtisResearcherExecutive Officer, DirectorLinked by 1 patent
- Andrew M. ClarkDirectorNamed in SEC Form D filings
- Brian P. BirkDirectorNamed in SEC Form D filings
- David M. BlivinDirectorNamed in SEC Form D filings
- Matthew P. FranklinExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 12 granted of 35- PendingPDE5 Inhibitor Powder Formulations And Methods Relating TheretoUSPTOApplication 19254244
- GrantedPDE5 Inhibitor Powder Formulations And Methods Relating TheretoUSPTOUS 12,364,701
- PendingMethods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersUSPTOApplication 19064180
Show all 35 patent records
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoOct 30, 2025 · Application 19254244Pending
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoJul 22, 2025 · US 12,364,701Granted
- Methods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersJun 19, 2025 · Application 19064180Pending
- Powder Dispersion Methods And DevicesApr 3, 2025 · Application 18978790Pending
- Methods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersApr 1, 2025 · US 12,263,174Granted
- Methods For Treatment Of Pulmonary HypertensionDec 5, 2024 · Application 18679971Pending
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoFeb 27, 2024 · US 11,911,390Granted
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoNov 7, 2023 · US 11,806,314Granted
- Powder Dispersion Methods And DevicesJan 5, 2023 · Application 17942534Pending
- Methods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersNov 8, 2022 · US 11,491,161Granted
- Methods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersNov 8, 2022 · US 11,491,160Granted
- Powder Dispersion Methods And DevicesOct 18, 2022 · US 11,471,623Granted
- Carrier-based Formulations And Related MethodsSep 22, 2022 · Application 17617902Pending
- Methods For Treatment Of Pulmonary HypertensionFeb 9, 2021 · US 10,912,778Granted
- Powder Inhaler, System And MethodsJun 16, 2020 · US 10,682,476Granted
- Powder Dispersion Methods And DevicesJan 7, 2020 · US 10,525,216Granted
- Inhaler To Deliver Substances For Prophylaxis Or Prevention Of Disease Or Injury Caused By The Inhalation Of Biological Or Chemical AgentsNov 5, 2019 · US 10,463,815Granted
- Powder Dispersion Devices And MethodsOct 15, 2019 · US 10,441,733Granted
- Powder Dispersion Devices And MethodsDec 27, 2018 · Application 15955508Pending
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoNov 3, 2016 · Application 15102957Pending
- Powder Dispersion Devices And MethodsDec 26, 2013 · Application 13776558Pending
- Dry Powder InhalerApplication PCTUS2011063816Pending
- Methods For Treatment Of Pulmonary HypertensionApplication PCTUS2024031885Pending
- Methods For Treatment Of Pulmonary HypertensionApplication 63470091Pending
- Carrier-based Formulations And Related MethodsApplication PCTUS2020036944Pending
- Targeted Delivery Of Carrier Compositions Within The Respiratory Tract And Methods Of Preparing The SameApplication 62859423Pending
- Powder Dispersion Devices And MethodsApplication PCTUS2018027982Pending
- Methods And Compositions For Treatment Of Pulmonary Hypertension And Other Lung DisordersApplication PCTUS2017066519Pending
- Powder Dispersion Devices And MethodsApplication 62486183Pending
- Methods of Treating Pulmonary Hypertension and Other Lung DisordersApplication 62434185Pending
- Powder Dispersion Methods And DevicesApplication PCTUS2016013456Pending
- Powder Inhaler, System And MethodsApplication PCTUS2015016891Pending
- PDE5 Inhibitor Powder Formulations And Methods Relating TheretoApplication PCTUS2014069392Pending
- Powder Dispersion Devices And MethodsApplication PCTUS2013046795Pending
- Powder Dispersion Devices And MethodsApplication PCTUS2013046779Pending
Related companies, and why
- Hydro-Gen LLCSimilar federal contract value in Medtech · null in contracts
- Pneuma Respiratory, Inc.Similar federal contract value in Medtech · null in contracts
- RALPHVR INC.Similar federal contract value in Medtech · null in contracts
- RESTOR3D, Inc.Similar federal contract value in Medtech · null in contracts
- WIDETRONIX INC.Similar federal contract value in Medtech · null in contracts
- Beyond Air, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .